1. Ayers, D. and Vandesompele, J. 2017. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. Genes, 8: e95.
2. Bi, L.L., Han, F., Zhang, X.M., and Li, Y.Y. 2018. LncRNA MT1JP acts as a tumor inhibitor via reciprocally regulating Wnt/beta-Catenin pathway in retinoblastoma. Eur. Rev. Med. Pharmacol. Sci., 22: 4204–4214.
3. Bowman, R.J., Mafwiri, M., Luthert, P., Luande, J., and Wood, M. 2008. Outcome of retinoblastoma in east Africa. Pediatr. Blood Cancer, 50: 160–162.
4. Broaddus, E., Topham, A., and Singh, A.D. 2009. Incidence of retinoblastoma in the USA: 1975–2004. Br. J. Ophthalmol., 93: 21–23.
5. Dimaras, H., Dimba, E.A., and Gallie, B.L. 2010. Challenging the global retinoblastoma survival disparity through a collaborative research effort. Br. J. Ophthalmol., 94: 1415–1416.